Keeping Pace: The Role of Immunotherapy in the Frontline Setting
Host: Mark A. Socinski, MD
Guest: Suresh S. Ramalingam, MD
While advanced non-small cell lung cancer remains incurable, innovations in treatment and new insights into the molecular pathogenesis of the disease have led to the development of treatments that significantly extend overall survival.
This activity will discuss the new scientific and clinical data that have rapidly emerged on immunotherapies in the frontline setting that are leading to changes in the standard of care. Find out how these newer therapeutics will be utilized in everyday clinical practice.